Clinical Trials Directory

Trials / Completed

CompletedNCT02793843

Ondansetron vs Ondansetron Plus Dexamethasone for Relieving Intrathecal Morphine Side Effects After C-section

A Randomized Study Evaluating Preventive Role of Ondansetron Versus Ondansetron Plus Dexamethasone for Postoperative Side Effects of Intrathecal Morphine Injection in Patients Undergoing Elective C-section

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
194 (actual)
Sponsor
Makassed General Hospital · Academic / Other
Sex
Female
Age
19 Years – 45 Years
Healthy volunteers
Not accepted

Summary

Background: Common adverse side effects related to the use of neuraxial opioids in the obstetric population include nausea, vomiting, and pruritus. Serotonin (5-HT3) receptor antagonists, in particular ondansetron, have been identified as possible antipruritic agents. It was reported that dexamethasone plus ondansetron is more effective than ondansetron for prevention of postoperative nausea and vomiting but no additional effect on treating pruritus. Objectives: The purpose of this study is to compare the effect of prophylactic ondansetron versus ondansetron plus dexamethasone after cesarean section on pruritus and postoperative nausea and vomiting (PONV). Methods: A prospective randomized double blind study that will be conducted between June 2016 and June 2017. Patients will be randomly allocated into two groups. The first group will receive 4 mg intravenous (IV) ondansetron while the other group will receive 4 mg IV ondansetron plus 8 mg dexamethasone.

Detailed description

A prospective randomized double blind study will be conducted between June 2016 and June 2017. The sealed envelope technique will be used to randomly allocate females scheduled for elective cesarean section into two groups. After obtaining informed consent, all eligible patients will receive spinal anesthesia. The first group will receive 4 mg intravenous (IV) ondansetron with 2 ml saline while the other group will receive 4 mg IV ondansetron plus 8 mg (2 ml) dexamethasone.

Conditions

Interventions

TypeNameDescription
DRUGOndansetron (Zofran)Intravenous administration of 4 mg ondansetron 15 minutes before spinal anesthesia
DRUGDexamethasone (Decadron)Intravenous administration of 8 mg dexamethasone 15 minutes before spinal anesthesia
OTHERSpinal anesthesiaIntrathecal anesthesia by 10 mg hyperbaric marcain, 5 mcg sufentanyl and 150 mcg morphine using 27 G spinal needle (27 G Quincke needle)

Timeline

Start date
2016-06-01
Primary completion
2017-06-15
Completion
2017-07-30
First posted
2016-06-08
Last updated
2017-11-06

Locations

1 site across 1 country: Lebanon

Source: ClinicalTrials.gov record NCT02793843. Inclusion in this directory is not an endorsement.